Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Design and synthesis of new 1,6-dihydropyrimidin-2-thio derivatives targeting VEGFR-2: Molecular docking and antiproliferative evaluation
Adel A. Marzouk, Salah A. Abdel‐Aziz, Kamal Abdelrahman, et al.
Bioorganic Chemistry (2020) Vol. 102, pp. 104090-104090
Closed Access | Times Cited: 45

Showing 1-25 of 45 citing articles:

Molecular hybrids: A five-year survey on structures of multiple targeted hybrids of protein kinase inhibitors for cancer therapy
Osama M. Soltan, Mai E. Shoman, Salah A. Abdel‐Aziz, et al.
European Journal of Medicinal Chemistry (2021) Vol. 225, pp. 113768-113768
Closed Access | Times Cited: 85
New quinoxaline derivatives as VEGFR-2 inhibitors with anticancer and apoptotic activity: Design, molecular modeling, and synthesis
Nawaf A. Alsaif, Mohammed A. Dahab, Mohammed M. Alanazi, et al.
Bioorganic Chemistry (2021) Vol. 110, pp. 104807-104807
Closed Access | Times Cited: 82
New benzothiazole hybrids as potential VEGFR-2 inhibitors: design, synthesis, anticancer evaluation, and in silico study
Mohammad M. Al‐Sanea, Abdelrahman Hamdi, Ahmed A. B. Mohamed, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 29
Design, synthesis, and antiproliferative properties of new 1,2,3-triazole-carboximidamide derivatives as dual EGFR/VEGFR-2 inhibitors
Mohamed A. Mahmoud, Anber F. Mohammed, Ola I. A. Salem, et al.
Journal of Molecular Structure (2023) Vol. 1282, pp. 135165-135165
Closed Access | Times Cited: 24
Design, synthesis, and apoptotic antiproliferative action of new 1,2,3-triazole/1,2,4-oxadiazole hybrids as dual EGFR/VEGFR-2 inhibitors
Mohamed A. Mahmoud, Anber F. Mohammed, Ola I. A. Salem, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2024) Vol. 39, Iss. 1
Open Access | Times Cited: 10
Discovery of new VEGFR-2 inhibitors based on bis([1, 2, 4]triazolo)[4,3-a:3',4'-c]quinoxaline derivatives as anticancer agents and apoptosis inducers
Nawaf A. Alsaif, Mohammed S. Taghour, Mohammed M. Alanazi, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2021) Vol. 36, Iss. 1, pp. 1093-1114
Open Access | Times Cited: 51
Recent advances in, and challenges of, anti-angiogenesis agents for tumor chemotherapy based on vascular normalization
Kai Wang, Qinhua Chen, Nanxin Liu, et al.
Drug Discovery Today (2021) Vol. 26, Iss. 11, pp. 2743-2753
Closed Access | Times Cited: 41
New 1,3,4‐oxadiazoles linked with the 1,2,3‐triazole moiety as antiproliferative agents targeting the EGFR tyrosine kinase
Mohamed A. Mahmoud, Anber F. Mohammed, Ola I. A. Salem, et al.
Archiv der Pharmazie (2022) Vol. 355, Iss. 6
Closed Access | Times Cited: 35
Novel piperine-carboximidamide hybrids: design, synthesis, and antiproliferative activity via a multi-targeted inhibitory pathway
Lamya H. Al-Wahaibi, Mohamed A. Mahmoud, Yaser A. Mostafa, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 38, Iss. 1, pp. 376-386
Open Access | Times Cited: 27
Design, synthesis, anti-acetylcholinesterase evaluation and molecular modelling studies of novel coumarin-chalcone hybrids
Aso Hameed Hasan, Sonam Shakya, Faiq H. S. Hussain, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 41, Iss. 21, pp. 11450-11462
Open Access | Times Cited: 18
Novel VEGFR‐2 Kinase Inhibitors as Anticancer Agents: A Review Focusing on SAR and Molecular Docking Studies (2016–2021)
S. Vishakha, Kumari Kajal, Sitanshu Mondal, et al.
Chemistry & Biodiversity (2023) Vol. 20, Iss. 2
Closed Access | Times Cited: 17
Recent Advances and Future Directions on Small Molecule VEGFR Inhibitors in Oncological Conditions
Amandeep Thakur, Mandeep Rana, Anshul Mishra, et al.
European Journal of Medicinal Chemistry (2024) Vol. 272, pp. 116472-116472
Closed Access | Times Cited: 6
Molecular Docking and Molecular Dynomic Simulation of Sulphonyl Hydrazides Derivatives as Vegfr-1 and Vegfr-2 Inhibators
naila naila, Adnan Shahzad, Ihsan Ullah, et al.
(2025)
Closed Access
Design, Synthesis, and Antibacterial Screening of Some Novel Heteroaryl-Based Ciprofloxacin Derivatives as DNA Gyrase and Topoisomerase IV Inhibitors
Lamya H. Al-Wahaibi, Amer A. Amer, Adel A. Marzouk, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 5, pp. 399-399
Open Access | Times Cited: 38
Design and synthesis of new triarylimidazole derivatives as dual inhibitors of BRAFV600E/p38α with potential antiproliferative activity
Bahaa G. M. Youssif, Ahmed M. Gouda, Amr H. Moustafa, et al.
Journal of Molecular Structure (2021) Vol. 1253, pp. 132218-132218
Closed Access | Times Cited: 38
Design, Synthesis, and Antiproliferative Activity of New 5-Chloro-indole-2-carboxylate and Pyrrolo[3,4-b]indol-3-one Derivatives as Potent Inhibitors of EGFRT790M/BRAFV600E Pathways
Lamya H. Al-Wahaibi, Anber F. Mohammed, Mostafa Abdelrahman, et al.
Molecules (2023) Vol. 28, Iss. 3, pp. 1269-1269
Open Access | Times Cited: 14
Novel 4-(piperazin-1-yl)quinolin-2(1H)-one bearing thiazoles with antiproliferative activity through VEGFR-2-TK inhibition
Abdelfattah Hassan, Mohamed Badr, Heba A. Hassan, et al.
Bioorganic & Medicinal Chemistry (2021) Vol. 40, pp. 116168-116168
Closed Access | Times Cited: 30
A comprehensive review of recent advances in the biological activities of quinazolines
Hesham A. M. Gomaa
Chemical Biology & Drug Design (2022) Vol. 100, Iss. 5, pp. 639-655
Closed Access | Times Cited: 18
Design, synthesis and antimicrobial activity of novel quinoline-2-one hybrids as promising DNA gyrase and topoisomerase IV inhibitors
Mohammed A. I. Elbastawesy, Fatma A. Mohamed, Islam Zaki, et al.
Journal of Molecular Structure (2023) Vol. 1278, pp. 134902-134902
Closed Access | Times Cited: 11
Computational design of quinoxaline molecules as VEGFR-2 inhibitors: QSAR modelling, pharmacokinetics, molecular docking, and dynamics simulation studies
Sagiru Hamza Abdullahi, Adamu Uzairu, Ammar Usman Danazumi, et al.
Biocatalysis and Agricultural Biotechnology (2023) Vol. 51, pp. 102787-102787
Closed Access | Times Cited: 11
Unveiling the impact: A decade review on dihydropyrimidinones (DHPMs) to combat breast cancer
Dhirajkumar Nikam, Puja Chaure, Lekha Dhindale, et al.
Journal of Molecular Structure (2024) Vol. 1308, pp. 138134-138134
Closed Access | Times Cited: 3
Novel pyrrolizines bearing 3,4,5-trimethoxyphenyl moiety: design, synthesis, molecular docking, and biological evaluation as potential multi-target cytotoxic agents
Ahmed M. Shawky, Nashwa A. Ibrahim, Ashraf N. Abdalla, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2021) Vol. 36, Iss. 1, pp. 1312-1332
Open Access | Times Cited: 21
New series of 4,6-diaryl pyrimidines: facile synthesis and antiproliferative activity as dual EGFR/VEGFR-2 inhibitors
Yaser A. Mostafa, Abdeljalil Assoud, Ahmed Desoky, et al.
Frontiers in Chemistry (2024) Vol. 12
Open Access | Times Cited: 2
Design, synthesis and cytotoxicity screening of new synthesized pyrimidine-5-carbonitrile derivatives showing marked apoptotic effect
Islam Zaki, Reham E. Masoud, Mohamed M. S. Hamoud, et al.
Journal of Molecular Structure (2022) Vol. 1259, pp. 132749-132749
Closed Access | Times Cited: 12
Design, Synthesis and Cytotoxicity Screening of New Thiazole Derivatives as Potential Anticancer Agents through VEGFR-2 Inhibition
Tarfah Al‐Warhi, Matokah M. Abualnaja, Ola A. Abu Ali, et al.
Symmetry (2022) Vol. 14, Iss. 9, pp. 1814-1814
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top